These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 4994685

  • 1. Piperacetazine (Quide) in the management of behavioral disorders in mildly retarded institutionalized boys.
    Kurland AA, Goldberg JB.
    Curr Ther Res Clin Exp; 1970 Dec; 12(12):798-804. PubMed ID: 4994685
    [No Abstract] [Full Text] [Related]

  • 2. Liquid butaperazine in the treatment of chronic psychosis in a mental health clinic.
    Clare G, Simeon J, Fink M.
    Curr Ther Res Clin Exp; 1969 Feb; 11(2):57-63. PubMed ID: 4388407
    [No Abstract] [Full Text] [Related]

  • 3. Evaluation of piperacetazine (Quide) injection in acute schizophrenics.
    Kiev A, Güclü B, Kulkarni AS.
    Curr Ther Res Clin Exp; 1972 Jul; 14(7):376-80. PubMed ID: 4625517
    [No Abstract] [Full Text] [Related]

  • 4. Relative efficacy of butaperazine and chlorpromazine in acute schizophrenia.
    Gershon S, Hekimian LJ, Burdock EI, Park S, Floyd A.
    Curr Ther Res Clin Exp; 1970 Dec; 12(12):810-8. PubMed ID: 4396420
    [No Abstract] [Full Text] [Related]

  • 5. Experience with pericyazine in profoundly and severely retarded children.
    Tischler B, Patriasz K, Beresford J, Bunting R.
    Can Med Assoc J; 1972 Jan 22; 106(2):136-41. PubMed ID: 4400557
    [Abstract] [Full Text] [Related]

  • 6. Piperacetazine in chronic mental patients: clinical observations and new urine color test.
    Forrest FM, Forrest IS.
    Curr Ther Res Clin Exp; 1972 Nov 22; 14(11):689-95. PubMed ID: 4629106
    [No Abstract] [Full Text] [Related]

  • 7. Predictors of therapeutic responsivity to thiothixene in schizophrenics.
    Sterlin C, Oliveros R, Ban TA.
    Int Z Klin Pharmakol Ther Toxikol; 1968 Jul 22; 1(5):394-6. PubMed ID: 4882603
    [No Abstract] [Full Text] [Related]

  • 8. Studies with new drugs in the treatment of convulsive disorders.
    Lehmann HE, Ban TA.
    Int Z Klin Pharmakol Ther Toxikol; 1968 Jan 22; 1(3):230-4. PubMed ID: 4387044
    [No Abstract] [Full Text] [Related]

  • 9. [Psychotropic effect of carbamazepin in nonepileptic children].
    Groh C, Rosemayr F, Birbaumer N.
    Med Monatsschr; 1971 Jul 22; 25(7):329-33. PubMed ID: 4935352
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Utilization of propericiazine in treatment of character disorders in mentally retarded children and adolescents].
    Vaneck L.
    Rev Neuropsychiatr Infant; 1969 Aug 22; 17(8):557-61. PubMed ID: 4391428
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A clinical study with propericiazine in chronic psychotic patients.
    Deutsch M, Ananth JV, Ban TA.
    Curr Ther Res Clin Exp; 1971 Jun 22; 13(6):353-8. PubMed ID: 4397391
    [No Abstract] [Full Text] [Related]

  • 18. Piperacetazine in ambulatory chronic schizophrenic patients.
    Rada RT, Donlon PT.
    Curr Ther Res Clin Exp; 1974 Feb 22; 16(2):124-9. PubMed ID: 4156665
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.